Ensysce Biosciences 株価情報 (NASDAQ: ENSC)

最新ニュース Ensysce Biosciences (NASDAQ:ENSC) 株価情報

Ensysce Biosciences

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Ensysce Biosciences Inc

Ensysce Biosciences Inc Warrants (05/12/2019)

JP Morgan analyst John Ivankoe maintains Dutch Bros (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) with a Overweight and raises the price target from $44 to $48.

News

Price Target

Analyst Ratings

BROS

JP Morgan Maintains Overweight on Dutch Bros, Raises Price Target to $48

Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Thursday</a>.
The company <a target="_blank" href="https://www.prnewswire.com/news-releases/planet-fitness-inc-announces-third-quarter-2024-results-302298159.html" rel="noreferrer noopener">reported</a> third-quarter adjusted earnings per share of 64 cents beating the street view of 58 cents. Quarterly sales of $292.25 million (+5.3%) beat the analyst consensus estimate of $285.87 million.
System-wide same-club sales (formerly same-store sales) rose 4.3%, while system-wide sales grew to $1.2 billion, up from $1.1 billion last year.
Adjusted EBITDA increased by $11.2 million, rising to $123.1 million from $111.9 million in the same period last year.
During the period, 21 new Planet Fitness clubs were opened, comprising 12 franchisee-owned and 9 corporate-owned, bringing the total to 2,637 clubs as of September 30.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41816755/security-company-geos-q3-miss-lower-isap-participants-offset-by-strategic-contracts" rel="noreferrer noopener">Security Company GEO&#8217;s Q3 Miss: Lower ISAP Participants Offset By Strategic Contracts</a>
&#8220;During the quarter, I had the opportunity to address franchisees, club employees, and our team members at our franchisee conference,&#8221; said&nbsp;Colleen Keating, Chief Executive Officer. &#8220;The enthusiasm the franchisees showed was highly encouraging.&#8221;
The company highlighted reaching a significant milestone with a $15 price increase for its Classic Card membership for new members, marking the first such increase in over 25 years, and emphasizing the continued value offered to members.
The company exited the quarter with cash and marketable securities of&nbsp;$530.7 million, with inventory worth $4.858 billion. Long-term debt, net of current maturities as of the quarter end, totaled $2.152 billion.
Outlook: For the year ending December 31, the company is reiterating its expectations of approximately 120 to 130 new equipment placements in franchisee-owned locations and 140 to 150 system-wide new club openings.
The company now expects revenue to increase in the 8% to 9% range (previously 4% to 6%), adjusted EBITDA to rise by 8% to 9% (previously 7% to 9%), and adjusted net income per diluted share to increase by 11% to 12% (previously 7% to 9%).
Price Action: PLNT shares are trading higher by 12.2% to $94.99 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41814047" target="_blank" rel="noreferrer noopener">Halliburton Misses Q3 Expectations As North America Sales Falter; International Growth On The Horizon</a></li>
</ul>

Earnings

Equities

Guidance

Markets

Movers

General

PLNT

Planet Fitness Flexes Q3 Earnings Muscle With EPS Beat, Sales Growth, And First Classic Card Membership Price Hike In 25 Years

RBC Capital analyst Matthew McKellar maintains Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) with a Outperform and raises the price target from $10 to $12.

RYAM

RBC Capital Maintains Outperform on Rayonier Adv Materials, Raises Price Target to $12

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$300.00</td>
<td>$33.2K</td>
<td>42.5K</td>
<td>197.0K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$210.00</td>
<td>$44.7K</td>
<td>4.9K</td>
<td>10.0K</td>
</tr>
<tr>
<td>MBLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$15.00</td>
<td>$25.4K</td>
<td>5.0K</td>
<td>6.4K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.00</td>
<td>$75.6K</td>
<td>48.0K</td>
<td>3.1K</td>
</tr>
<tr>
<td>W</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$45.00</td>
<td>$119.2K</td>
<td>15.9K</td>
<td>2.0K</td>
</tr>
<tr>
<td>TPR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$48.00</td>
<td>$168.0K</td>
<td>726</td>
<td>703</td>
</tr>
<tr>
<td>ANF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$135.00</td>
<td>$195.0K</td>
<td>794</td>
<td>702</td>
</tr>
<tr>
<td>PLNT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$100.00</td>
<td>$27.6K</td>
<td>119</td>
<td>548</td>
</tr>
<tr>
<td>KSS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$19.00</td>
<td>$34.1K</td>
<td>2.4K</td>
<td>537</td>
</tr>
<tr>
<td>XPEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$15.00</td>
<td>$25.5K</td>
<td>191</td>
<td>198</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option sweep with bullish sentiment. It expires in 1 day(s) on November 8, 2024. Parties traded 74 contract(s) at a $300.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $33.2K, with a price of $450.0 per contract. There were 42589 open contracts at this strike prior to today, and today 197005 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option trade with bullish sentiment. It expires in 106 day(s) on February 21, 2025. Parties traded 30 contract(s) at a $210.00 strike. The total cost received by the writing party (or parties) was $44.7K, with a price of $1490.0 per contract. There were 4982 open contracts at this strike prior to today, and today 10028 contract(s) were bought and sold. 
• For MBLY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>), we notice a call option trade that happens to be bullish, expiring in 8 day(s) on November 15, 2024. This event was a transfer of 105 contract(s) at a $15.00 strike. The total cost received by the writing party (or parties) was $25.4K, with a price of $242.0 per contract. There were 5052 open contracts at this strike prior to today, and today 6455 contract(s) were bought and sold. 
• Regarding NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), we observe a call option sweep with bullish sentiment. It expires in 71 day(s) on January 17, 2025. Parties traded 1400 contract(s) at a $6.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $75.6K, with a price of $54.0 per contract. There were 48024 open contracts at this strike prior to today, and today 3128 contract(s) were bought and sold. 
• Regarding W (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>), we observe a call option sweep with bearish sentiment. It expires in 43 day(s) on December 20, 2024. Parties traded 547 contract(s) at a $45.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $119.2K, with a price of $218.0 per contract. There were 15977 open contracts at this strike prior to today, and today 2074 contract(s) were bought and sold. 
• Regarding TPR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>), we observe a call option trade with bearish sentiment. It expires in 8 day(s) on November 15, 2024. Parties traded 400 contract(s) at a $48.00 strike. The total cost received by the writing party (or parties) was $168.0K, with a price of $420.0 per contract. There were 726 open contracts at this strike prior to today, and today 703 contract(s) were bought and sold. 
• Regarding ANF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>), we observe a call option trade with bearish sentiment. It expires in 8 day(s) on November 15, 2024. Parties traded 199 contract(s) at a $135.00 strike. The total cost received by the writing party (or parties) was $195.0K, with a price of $980.0 per contract. There were 794 open contracts at this strike prior to today, and today 702 contract(s) were bought and sold. 
• Regarding PLNT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>), we observe a call option sweep with neutral sentiment. It expires in 71 day(s) on January 17, 2025. Parties traded 114 contract(s) at a $100.00 strike. This particular call needed to be split into 22 different trades to become filled. The total cost received by the writing party (or parties) was $27.6K, with a price of $243.0 per contract. There were 119 open contracts at this strike prior to today, and today 548 contract(s) were bought and sold. 
• For KSS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>), we notice a put option sweep that happens to be bearish, expiring in 8 day(s) on November 15, 2024. This event was a transfer of 412 contract(s) at a $19.00 strike. This particular put needed to be split into 22 different trades to become filled. The total cost received by the writing party (or parties) was $34.1K, with a price of $83.0 per contract. There were 2450 open contracts at this strike prior to today, and today 537 contract(s) were bought and sold. 
• Regarding XPEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>), we observe a put option trade with bearish sentiment. It expires in 106 day(s) on February 21, 2025. Parties traded 94 contract(s) at a $15.00 strike. The total cost received by the writing party (or parties) was $25.5K, with a price of $272.0 per contract. There were 191 open contracts at this strike prior to today, and today 198 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AMZN

MBLY

TSLA

XPEV

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TOST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$36.00</td>
<td>$55.2K</td>
<td>83</td>
<td>3.7K</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$240.00</td>
<td>$29.0K</td>
<td>2.9K</td>
<td>3.5K</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$60.00</td>
<td>$25.2K</td>
<td>1.0K</td>
<td>2.3K</td>
</tr>
<tr>
<td>UPST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$50.00</td>
<td>$52.3K</td>
<td>1.7K</td>
<td>2.3K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$44.00</td>
<td>$155.6K</td>
<td>7.0K</td>
<td>2.2K</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$85.00</td>
<td>$194.9K</td>
<td>12.0K</td>
<td>1.6K</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$130.00</td>
<td>$263.0K</td>
<td>782</td>
<td>1.3K</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$270.00</td>
<td>$58.8K</td>
<td>1.4K</td>
<td>688</td>
</tr>
<tr>
<td>FHN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$21.00</td>
<td>$28.4K</td>
<td>0</td>
<td>154</td>
</tr>
<tr>
<td>AXP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$390.00</td>
<td>$28.1K</td>
<td>52</td>
<td>152</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding TOST (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>), we observe a call option sweep with bullish sentiment. It expires in 8 day(s) on November 15, 2024. Parties traded 670 contract(s) at a $36.00 strike. This particular call needed to be split into 55 different trades to become filled. The total cost received by the writing party (or parties) was $55.2K, with a price of $83.0 per contract. There were 83 open contracts at this strike prior to today, and today 3735 contract(s) were bought and sold. 
• Regarding JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we observe a put option trade with bullish sentiment. It expires in 1 day(s) on November 8, 2024. Parties traded 100 contract(s) at a $240.00 strike. The total cost received by the writing party (or parties) was $29.0K, with a price of $290.0 per contract. There were 2990 open contracts at this strike prior to today, and today 3504 contract(s) were bought and sold. 
• Regarding AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we observe a call option sweep with bearish sentiment. It expires in 1 day(s) on November 8, 2024. Parties traded 265 contract(s) at a $60.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $25.2K, with a price of $95.0 per contract. There were 1025 open contracts at this strike prior to today, and today 2377 contract(s) were bought and sold. 
• Regarding UPST (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>), we observe a put option sweep with bullish sentiment. It expires in 8 day(s) on November 15, 2024. Parties traded 161 contract(s) at a $50.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $52.3K, with a price of $325.0 per contract. There were 1735 open contracts at this strike prior to today, and today 2353 contract(s) were bought and sold. 
• Regarding BAC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), we observe a call option sweep with bearish sentiment. It expires in 1 day(s) on November 8, 2024. Parties traded 1727 contract(s) at a $44.00 strike. This particular call needed to be split into 141 different trades to become filled. The total cost received by the writing party (or parties) was $155.6K, with a price of $90.0 per contract. There were 7064 open contracts at this strike prior to today, and today 2203 contract(s) were bought and sold. 
• Regarding PYPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), we observe a call option sweep with bearish sentiment. It expires in 71 day(s) on January 17, 2025. Parties traded 619 contract(s) at a $85.00 strike. This particular call needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $194.9K, with a price of $315.0 per contract. There were 12069 open contracts at this strike prior to today, and today 1604 contract(s) were bought and sold. 
• For FUTU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>), we notice a call option trade that happens to be bearish, expiring in 43 day(s) on December 20, 2024. This event was a transfer of 616 contract(s) at a $130.00 strike. The total cost received by the writing party (or parties) was $263.0K, with a price of $427.0 per contract. There were 782 open contracts at this strike prior to today, and today 1387 contract(s) were bought and sold. 
• Regarding COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we observe a call option sweep with bearish sentiment. It expires in 22 day(s) on November 29, 2024. Parties traded 48 contract(s) at a $270.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $58.8K, with a price of $1225.0 per contract. There were 1473 open contracts at this strike prior to today, and today 688 contract(s) were bought and sold. 
• Regarding FHN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>), we observe a put option trade with neutral sentiment. It expires in 106 day(s) on February 21, 2025. Parties traded 154 contract(s) at a $21.00 strike. The total cost received by the writing party (or parties) was $28.4K, with a price of $185.0 per contract. There were 0 open contracts at this strike prior to today, and today 154 contract(s) were bought and sold. 
• For AXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), we notice a call option sweep that happens to be bullish, expiring in 316 day(s) on September 19, 2025. This event was a transfer of 62 contract(s) at a $390.00 strike. This particular call needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $28.1K, with a price of $457.0 per contract. There were 52 open contracts at this strike prior to today, and today 152 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFRM

COIN

FUTU

PYPL

TOST

UPST

10 Financials Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$147.00</td>
<td>$95.3K</td>
<td>5.1K</td>
<td>39.3K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$25.00</td>
<td>$36.3K</td>
<td>7.3K</td>
<td>19.5K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$422.50</td>
<td>$32.5K</td>
<td>5.6K</td>
<td>7.4K</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$250.00</td>
<td>$53.2K</td>
<td>4.6K</td>
<td>6.6K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$17.00</td>
<td>$420.6K</td>
<td>2.9K</td>
<td>4.7K</td>
</tr>
<tr>
<td>CLSK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$15.00</td>
<td>$39.7K</td>
<td>17.2K</td>
<td>4.0K</td>
</tr>
<tr>
<td>WULF</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$10.00</td>
<td>$34.0K</td>
<td>329</td>
<td>3.7K</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$35.00</td>
<td>$38.3K</td>
<td>9.1K</td>
<td>2.5K</td>
</tr>
<tr>
<td>UMC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$7.00</td>
<td>$39.5K</td>
<td>2.6K</td>
<td>2.4K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$200.00</td>
<td>$37.5K</td>
<td>10.1K</td>
<td>2.3K</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we observe a put option sweep with bearish sentiment. It expires in 1 day(s) on November 8, 2024. Parties traded 990 contract(s) at a $147.00 strike. This particular put needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $95.3K, with a price of $98.0 per contract. There were 5125 open contracts at this strike prior to today, and today 39381 contract(s) were bought and sold. 
• For SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we notice a call option sweep that happens to be bearish, expiring in 1 day(s) on November 8, 2024. This event was a transfer of 300 contract(s) at a $25.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $36.3K, with a price of $121.0 per contract. There were 7360 open contracts at this strike prior to today, and today 19547 contract(s) were bought and sold. 
• For MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we notice a call option sweep that happens to be bearish, expiring in 1 day(s) on November 8, 2024. This event was a transfer of 100 contract(s) at a $422.50 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $32.5K, with a price of $325.0 per contract. There were 5653 open contracts at this strike prior to today, and today 7465 contract(s) were bought and sold. 
• Regarding APP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), we observe a call option trade with bearish sentiment. It expires in 71 day(s) on January 17, 2025. Parties traded 25 contract(s) at a $250.00 strike. The total cost received by the writing party (or parties) was $53.2K, with a price of $2130.0 per contract. There were 4648 open contracts at this strike prior to today, and today 6624 contract(s) were bought and sold. 
• Regarding CORZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>), we observe a call option sweep with bearish sentiment. It expires in 161 day(s) on April 17, 2025. Parties traded 1717 contract(s) at a $17.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $420.6K, with a price of $245.0 per contract. There were 2917 open contracts at this strike prior to today, and today 4756 contract(s) were bought and sold. 
• Regarding CLSK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>), we observe a call option sweep with bullish sentiment. It expires in 8 day(s) on November 15, 2024. Parties traded 748 contract(s) at a $15.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $39.7K, with a price of $53.0 per contract. There were 17236 open contracts at this strike prior to today, and today 4049 contract(s) were bought and sold. 
• For WULF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>), we notice a call option trade that happens to be neutral, expiring in 161 day(s) on April 17, 2025. This event was a transfer of 200 contract(s) at a $10.00 strike. The total cost received by the writing party (or parties) was $34.0K, with a price of $170.0 per contract. There were 329 open contracts at this strike prior to today, and today 3725 contract(s) were bought and sold. 
• Regarding MARA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), we observe a call option trade with bullish sentiment. It expires in 134 day(s) on March 21, 2025. Parties traded 243 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $38.3K, with a price of $158.0 per contract. There were 9184 open contracts at this strike prior to today, and today 2585 contract(s) were bought and sold. 
• Regarding UMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>), we observe a call option sweep with bearish sentiment. It expires in 8 day(s) on November 15, 2024. Parties traded 1314 contract(s) at a $7.00 strike. This particular call needed to be split into 52 different trades to become filled. The total cost received by the writing party (or parties) was $39.5K, with a price of $30.0 per contract. There were 2687 open contracts at this strike prior to today, and today 2424 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option sweep with bullish sentiment. It expires in 225 day(s) on June 20, 2025. Parties traded 10 contract(s) at a $200.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $37.5K, with a price of $3750.0 per contract. There were 10135 open contracts at this strike prior to today, and today 2358 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

CLSK

Core Scientific, Inc. - Class A Common Stock

CORZ

MARA

MSFT

NVDA

SMCI

WULF

10 Information Technology Stocks With Whale Alerts In Today's Session

Lucid Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) has started taking orders for its electric Gravity SUV <a target="_blank" href="https://www.benzinga.com/news/24/10/41617327/lucid-to-start-taking-orders-for-gravity-suv-next-week-but-only-for-premium-variant-priced-at-about" rel="noreferrer noopener">as planned</a>.
The Gravity will likely rival&nbsp;Tesla Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Model X SUV. The company launched the configuration tool for its new Lucid Gravity Grand Touring, allowing customers to customize and order the vehicle on <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41807763/lucid-gravity-now-available-to-configure-and-order-on-the-lucid-motors-website" rel="noreferrer noopener">its website</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41807409/himax-q3-earnings-revenue-beats-forecast-ceo-highlights-growth-in-automotive-ai-oled-sectors-sets-c" rel="noreferrer noopener">Himax Q3 Earnings: Revenue Beats Forecast, CEO Highlights Growth in Automotive, AI, OLED Sectors, Sets Cautious Q4 Guidance</a>
Production for this advanced electric SUV model is slated to begin at the end of 2024.
The Lucid Gravity SUV combines luxury, spacious design, and range into a unique driving experience.
Lucid Gravity offers the space and utility of a full-size SUV within a midsize frame. This design accommodates up to seven passengers, blending functionality and luxury with a compact exterior that enhances maneuverability, the company said in the press release.
The Gravity lineup includes the Grand Touring variant, priced at $94,900, and the Touring model, expected to launch in late 2025, priced at $79,900.
The Grand Touring version delivers 828 horsepower and an impressive projected range of over 440 miles per charge.
The SUV includes Lucid's DreamDrive driver-assistance system as standard, with upgrades available through DreamDrive Premium and DreamDrive Pro for enhanced features like hands-free driving, adaptive lane change, and traffic light recognition.
The Gravity launch is critical for Lucid's future. Although the company has boosted Air sedan sales recently by lowering prices and introducing a more affordable trim, its sales remain far below projections made during its $4 billion reverse merger in 2021, TechCrunch <a target="_blank" href="https://techcrunch.com/2024/11/07/lucid-motors-starts-taking-orders-for-its-existential-gravity-suv/" rel="noreferrer noopener">reports</a>.
To support its financial reserves, Lucid has turned repeatedly to its majority owner, Saudi Arabia, for additional funding this year.
One of Lucid's main challenges is affordability; its vehicles exceed the federal EV tax credit price cap at the point of sale.
However, a $7,500 tax credit applies to leases—a benefit that depends on the federal tax credit remaining in place when President-elect Donald Trump takes office next year.
Lucid Group stock plunged over 45% year-to-date.
Price Action: LCID stock is up 3.99% at $2.21 at the last check Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41811828/epam-q3-earnings-beats-expectations-rising-margins-ceo-flags-neoris-acquisition" target="_blank" rel="noreferrer noopener">EPAM Q3 Earnings: Beats Expectations, Rising Margins, CEO Flags NEORIS Acquisition</a></li>
</ul>
Photo courtesy: Lucid

LCID

Lucid Opens Orders for New Gravity SUV, Taking Aim at Tesla's Model X

JP Morgan analyst Bryan Smilek maintains Duolingo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) with a Overweight and raises the price target from $303 to $360.

DUOL

JP Morgan Maintains Overweight on Duolingo, Raises Price Target to $360

JP Morgan analyst Drew Chamberlain maintains Centuri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRI#NYSE">CTRI</a>) with a Underweight and raises the price target from $16 to $17.

CTRI

JP Morgan Maintains Underweight on Centuri Holdings, Raises Price Target to $17

RBC Capital analyst Matthew Hedberg maintains PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) with a Outperform and raises the price target from $202 to $230.

RBC Capital Maintains Outperform on PTC, Raises Price Target to $230

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBT#NASDAQ">CLBT</a>) with a Overweight and raises the price target from $21 to $22.

CLBT

JP Morgan Maintains Overweight on Cellebrite DI, Raises Price Target to $22

RBC Capital analyst Gregory Renza maintains Pacira BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCRX#NASDAQ">PCRX</a>) with a Sector Perform and raises the price target from $15 to $16.

PCRX

RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $16

Investors with a lot of money to spend have taken a bearish stance on Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with SAVA, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for Cassava Sciences.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 50%, bearish.
Out of all of the options we uncovered, 7 are puts, for a total amount of $321,665, and there was 1 call, for a total amount of $38,840.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $10.0 and $50.0 for Cassava Sciences, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Cassava Sciences's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Cassava Sciences's substantial trades, within a strike price spectrum from $10.0 to $50.0 over the preceding 30 days.
<h3>Cassava Sciences Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731000684_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$8.5</td>
<td>$7.95</td>
<td>$8.5</td>
<td>$23.00</td>
<td>$85.0K</td>
<td>3</td>
<td align="right">125</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.15</td>
<td>$7.7</td>
<td>$8.15</td>
<td>$15.00</td>
<td>$72.5K</td>
<td>2.3K</td>
<td align="right">109</td>
</tr>
<tr>
<td>SAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$4.3</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$30.00</td>
<td>$38.8K</td>
<td>202</td>
<td align="right">393</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$35.2</td>
<td>$33.9</td>
<td>$34.6</td>
<td>$50.00</td>
<td>$34.6K</td>
<td>66</td>
<td align="right">10</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$34.8</td>
<td>$34.25</td>
<td>$34.4</td>
<td>$50.00</td>
<td>$34.4K</td>
<td>66</td>
<td align="right">40</td>
</tr>
</tbody>
</table>

<h3>About Cassava Sciences</h3>
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
After a thorough review of the options trading surrounding Cassava Sciences, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Cassava Sciences's Current Market Status</h3>
<ul>
<li>With a volume of 657,696, the price of SAVA is down -0.58% at $26.41. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 0 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cassava Sciences with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

SAVA

Looking At Cassava Sciences's Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on Block.
Looking at options history for Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) we detected 19 trades.
If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 47% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $259,286 and 11, calls, for a total amount of $458,549.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $47.5 to $110.0 for Block over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Block options trades today is 2342.05 with a total volume of 4,780.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Block's big money trades within a strike price range of $47.5 to $110.0 over the last 30 days.
<h3>Block 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731000679_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$7.9</td>
<td>$7.5</td>
<td>$7.8</td>
<td>$77.50</td>
<td>$78.0K</td>
<td>68</td>
<td align="right">101</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$30.2</td>
<td>$29.65</td>
<td>$29.85</td>
<td>$47.50</td>
<td>$74.6K</td>
<td>111</td>
<td align="right">25</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$8.0</td>
<td>$8.0</td>
<td>$8.0</td>
<td>$70.00</td>
<td>$56.0K</td>
<td>3.2K</td>
<td align="right">280</td>
</tr>
<tr>
<td>SQ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.6</td>
<td>$6.55</td>
<td>$6.6</td>
<td>$77.50</td>
<td>$46.2K</td>
<td>808</td>
<td align="right">152</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.73</td>
<td>$2.65</td>
<td>$2.73</td>
<td>$85.00</td>
<td>$40.4K</td>
<td>6.9K</td>
<td align="right">220</td>
</tr>
</tbody>
</table>

<h3>About Block</h3>
Founded in 2009, Block provides payment services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. In 2023, Square's payment volume was a little over $200 million.
<h3>Current Position of Block</h3>
<ul>
<li>Trading volume stands at 5,127,017, with SQ's price down by -0.73%, positioned at $77.07.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>What The Experts Say On Block</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $88.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $88. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Block with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Behind the Scenes of Block's Latest Options Trends

JP Morgan analyst Pablo Zuanic maintains Bowhead Specialty Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOW#NYSE">BOW</a>) with a Neutral and raises the price target from $26 to $30.

JP Morgan Maintains Neutral on Bowhead Specialty Holding, Raises Price Target to $30

United Parks &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRKS#NYSE">PRKS</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41801451/united-parks-resorts-inc-reports-third-quarter-and-first-nine-months-2024-results" rel="noreferrer noopener">third-quarter 2024</a> revenue of $545.901 million, a slight decline of 0.4% year-over-year, missing the consensus estimate of $550.473 million.
Third quarter EPS was $2.08 (+8.3% year over year), below the analyst consensus of $2.22.
Attendance reached 7 million guests. That&#8217;s down by about 100,000 or 1.4% compared to Q3 2023. The attendance decline was mainly due to Hurricanes Debby and Helene, during peak periods.
Total revenue per capita rose 1.0% to $77.66 from Q3 2023. Admission per capita increased 0.5% to $42.24, while in-park spending per capita grew 1.6% to a record $35.42.
&#8220;The combined impact of the calendar shift and the meaningfully worse weather was approximately 320,000 guests, adjusting for these impacts, attendance would have increased approximately 3% compared to the prior year quarter, as we continue to see strong demand for our parks during normalized operating conditions and we are growing total revenue per capita,&#8221; United Parks CEO Marc Swanson said.
The company delivered record in-park per capita spending during the quarter, Swanson added, citing growth for 17 of the last 18 quarters of growth
Adjusted EBITDA was $258.4 million for the quarter, a decline of 3% YoY, and the margin contracted 126 bps to 47.3%.
In Q3, the company repurchased 4.1 million shares for $211.7 million. Some $74.9 million remains in the program as of Sept. 30. An additional 0.8 million shares were repurchased for $37.7 million by November 6.
The operating cash flow for the third quarter was $122.998 million, down from $163.556 million a year ago. Free cash flow stood at $67.605 million.
Looking ahead to 2025, the company reports strong forward demand, with ticket sales, group bookings, and Discovery Cove bookings showing double-digit growth over the last year. The recently launched premium pass program, featuring enhanced benefits, has driven sales up over 10% since its debut. Year-to-date results continue to highlight the resilience of the business model and the rising demand for the parks&#8217; unique offerings.
Total liquidity stood at $759 million with a net leverage ratio of 2.98x as of Sept. 30. In the quarter, the company expanded its credit facility from $390 million to $700 million, reducing costs by 50 basis points.
Price Action: PRKS shares are trading higher by 2.08% to $58.3 at last check Thursday.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41814589/why-trumps-boost-to-treasury-yields-inflation-expectations-may-weaken-feds-efforts-">Why Trump&#8217;s Boost To Treasury Yields, Inflation Expectations May Weaken Fed&#8217;s Efforts To Cut Interest Rates</a></li>
</ul>

PRKS

United Parks Q3 Revenue Falls Short Due To Hurricane Impact, But Future Demand And Sales Show Resilience

<a href="https://www.benzinga.com/personal-finance/24/11/41757209/if-you-do-this-prepare-to-spend-thousands-on-non-necessities-says-suze-orman-her-solution-learn-">Suze Orman</a>, a trusted personal finance expert worldwide, emphasizes that individuals must be vigilant about their benefit selections during the annual open enrollment period.&nbsp;
With health plan premiums expected to increase, Orman advises closely reviewing coverage options. High-deductible health plans (HDHPs), which come with lower premiums, might be worth considering for those with robust emergency funds. However, she cautions, "Never opt for an HDHP if you lack the savings to cover the deductible."&nbsp;
Don't Miss:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li><a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a></li>
</ul>
An HDHP can be paired with a Health Savings Account (HSA), a powerful tool that offers a "triple tax break" – contributions grow tax-free, are tax-deductible and withdrawals for medical expenses are untaxed. Plus, some employers match contributions, adding an extra boost to savings.
Beyond health coverage, Medicaid expansions in 40 states have broadened access for low-income families, but there's ongoing debate about how financially sustainable this will be in the long run.&nbsp;
Policy experts, like those at the Kaiser Family Foundation, highlight the importance of keeping up with changes in Medicaid eligibility and benefits as states adjust policies. These expansions, though beneficial, come with a need for beneficiaries to stay informed on any premium adjustments or updates in coverage tiers.
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
For those with dependents, relying solely on employer-provided life insurance is a mistake, <a href="https://www.benzinga.com/personal-finance/financial-advisors/24/10/41553671/the-wealthy-follow-suze-ormans-golden-rule-for-getting-rich-she-says-theres-1">according to Orman</a>. Employer policies typically cover only one to two years of salary – far from adequate. "My advice," she stresses, "is to aim for a life insurance policy that's 20 to 25 times your current salary."&nbsp;
This recommendation is particularly vital for families with young children or a stay-at-home parent who would otherwise face hefty costs for child care if the caregiver passes away unexpectedly.
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
Orman also points out the importance of emergency savings, noting that many employers now offer programs to help workers build a financial safety net. Some companies even match contributions to these savings plans, providing a solid foundation against life's inevitable surprises.&nbsp;
If one's employer doesn't offer this benefit, Orman suggests asking HR about "split deposit" options, allowing a portion of each paycheck to be automatically directed into a savings account. For those who need more support, she recommends SecureSave, a tool she cofounded to give employees a straightforward way to build emergency savings.
See Also: According to Vanguard&#8217;s Advisor&#8217;s Alpha Study, working with a financial advisor can result in approximately 3% higher net returns annually,<a href="https://www.benzinga.com/money/3-percent-advantage-financial-advisor"> here are the benefits of partnering with a financial advisor and how to find the right one near you in minutes.</a>
Retirement planning is another area Orman urges individuals not to overlook. She recommends saving at least 15% of one's income for retirement, combining personal and employer contributions. Increasing the contribution rate can make a significant difference over time for employees not yet at that target.
Orman's advice comes when economic uncertainty also impacts food security, with organizations like the Food and Agriculture Organization raising concerns about food affordability worldwide. Programs like the Supplemental Nutrition Assistance Program (SNAP) have become essential to many households.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Suze Orman Warns It's On You To Make Sure You Have The Right Coverage For 2025 And Beyond – 'Don't Rely On Workplace Life Insurance'

JP Morgan analyst Michael Rehaut maintains Beacon Roofing Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NASDAQ">BECN</a>) with a Overweight and raises the price target from $110 to $119.

BECN

JP Morgan Maintains Overweight on Beacon Roofing Supply, Raises Price Target to $119

RBC Capital analyst Mike Dahl maintains Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) with a Outperform and raises the price target from $213 to $217.

RBC Capital Maintains Outperform on Owens-Corning, Raises Price Target to $217

Alyse Amores' trading journey started in 2017 with just $300, a leap of faith and the determination of a single mother wanting more for her family.&nbsp;
In her interview with Trading Nut, Amores detailed how she grew that initial $300 into a seven-figure trading account in just five years – without a background in finance or investing. Her story isn't <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">just about financial success</a>, but also about discipline, strategy and resilience. Here are her most valuable lessons for new traders.
Don't Miss:
<ul>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
<li>This well known prop trading firm is offering 100% of your first $25,000 profit per account and 90% after that. <a href="https://www.benzinga.com/money/apex-trader-funding">Here's how to get a special 50% OFF CODE that lets you start out with monthly investments as low as $147 today.</a></li>
</ul>
Starting with Small, Realistic Goals
Amores <a href="https://www.benzinga.com/personal-finance/24/06/39439265/single-mom-with-1-3-million-from-divorce-cant-afford-8-000-monthly-rent-dave-ramsey-says-its-tim">didn't jump in with massive goals</a> or big capital. "My first goal was just to earn five or six hundred dollars a week," she explained. "If I could replace my side hustle, that would already be huge for me." She only invested $300 initially, even though she could have put in more. Her approach was simple: if she couldn't grow $300, she wasn't ready to trade larger amounts. "If you can't grow $300, you won't be able to grow $3,000 or $30,000," she noted.
As her skills developed, so did her targets. Within six months, her weekly earnings exceeded her biweekly paycheck and she built a full year's salary in savings – enough to safely leave her job. "I couldn't just leave my job and hope for the best. I had to be prepared and have a safety net for my family," she said. This cautious approach allowed her to build her confidence and skills without feeling pressured to "make it big" overnight.
Trending: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic&nbsp;</a>
Learning from Mentors and the Power of Networking
One critical element in Amores' journey was finding experienced traders to guide her. Rather than trying to teach herself everything, she sought out mentors at every new level. "Try to learn from someone vetted, with proof they are who they say they are," she advised, adding that a solid mentor saved her from wasting time on beginner strategies when she was ready for more advanced skills.
Through networking, Amores went from managing her own account to working with proprietary trading firms and eventually handling larger fund accounts. "Every fund I've traded for came through referrals," she explained. "You never know who you're talking to, so always show up as your best self." These connections shaped her trading journey, each one opening new doors and bigger opportunities.
Trending: With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today.</a>
Managing Emotions Through Visualization and Focused Preparation
For Amores, successful trading isn't only about strategy. Mental resilience plays a significant role. To manage the stress of large trades, she developed a daily routine that includes visualization techniques.&nbsp;
"I visualize myself trading calmly, even when numbers aren't going my way," she said. She learned to avoid impulsive decisions that could undermine her trades by focusing on staying calm. This emotional control, coupled with a focused morning routine – whether calming music, affirmations or reviewing her goals – allowed her to approach each trading day clearheaded and prepared.
See Also: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a>
Looking to the Future – With Big Goals and Bigger Ambitions
Today, Amores <a href="https://www.benzinga.com/personal-finance/24/06/39339348/can-you-guess-how-much-of-the-stock-market-the-richest-10-own-hint-its-more-than-you-think">trades multimillion-dollar accounts</a> and aspires to handle billion-dollar allocations. For her, trading has been about more than just building wealth; it's about challenging herself and achieving new milestones.&nbsp;
Her journey reminds us that success in trading comes from persistence, self-discipline and a commitment to continuous improvement. Amores' story isn't just inspiring – it's a practical guide for anyone looking to make their mark in trading.
Read Next:
<ul>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's an opportunity to invest at $1,000 for only $0.50/share today.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

A Single Mom Transformed $300 Into A 7-Figure Trading Empire in Just 5 Years – Here Are Her Best Tips for New Traders

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Fisker (NYSE:<a href="https://investorplace.com/stock-quotes/fsr-stock-quote/">FSR</a>) stock is moving on Monday after the electric vehicle (EV) company announced that it has secured an <a href="https://investors.fiskerinc.com/news/news-details/2024/Fisker-Announces-Receipt-of-Financing-Commitment-of-Up-to-150-Million-and-Provides-Business-Update/default.aspx">additional $150 million in funding</a>.



According to a press release from Fisker, the company&rsquo;s new funding comes from the holder of its 2025-dated convertible notes. It&rsquo;s also worth noting that this funding is being split into four tranches.



Fisker also mentions that this funding is only available if it meets certain conditions. Chief among these is the filing of the company&rsquo;s Form 10-K for 2023.



Investors will keep in mind that Fisker still has inventory from 2023 on hand. Combined with what has been produced in 2024, it has an excess inventory of over $200 million. The company is pausing production for six weeks starting today to align its inventory.



It&rsquo;s also worth mentioning that Fisker is still in talks with a large automaker for an investment. This has it hoping for funding to develop an EV platform with the manufacturer.



<h2>How This Affects FSR Stock Today</h2>



Despite news of the additional financing, shares of FSR stock are still falling on Monday. This has the stock down 12% this morning.



That drop for FSR stock comes alongside some 136 million shares changing hands. That&rsquo;s a massive surge in trading volume compared to the company&rsquo;s average of about 67 million shares.



Investors searching for more of the latest stock market stories are in luck!



We have all of the hottest stock market news ready to go on Monday! A few examples include what has shares of Nio&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nio-stock-quote/">NIO</a>), Xpeng&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/xpev-stock-quote/">XPEV</a>) and Ensysce Biosciences&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ensc-stock-quote/">ENSC</a>) stock moving today. All of that information is ready to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/03/nio-stock-ceo-william-li-says-second-gen-nio-phone-is-underway/">NIO Stock: CEO William Li Says Second-Gen Nio Phone Is Underway</a></li>



<li><a href="https://investorplace.com/2024/03/xpev-stock-alert-xpeng-pops-on-news-of-cheaper-ev-brand/">XPEV Stock Alert: Xpeng Pops on News of Cheaper EV Brand</a></li>



<li><a href="https://investorplace.com/earning-results/2024/03/ensc-stock-earnings-ensysce-biosciences-for-q4-of-2023/">ENSC Stock Earnings: Ensysce Biosciences Misses EPS, Beats Revenue for Q4 2023</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">Penny Stocks &mdash;&nbsp;How to Profit Without Getting Scammed</a>



On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/fsr-stock-the-150-million-reason-fisker-shares-are-moving-today/">FSR Stock: The $150 Million Reason Fisker Shares Are Moving Today</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FSR Stock: The $150 Million Reason Fisker Shares Are Moving Today

Ensysce Biosciences GAAP EPS of -$0.55

Ensysce Biosciences regains Nasdaq compliance

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Ensysce Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ensc-stock-quote/">ENSC</a>) just reported results for the first quarter of 2024.<ul><li>Ensysce Biosciences reported earnings per share of -55 cents. This was above the analyst estimate for EPS of -93 cents.</li><li>The company reported revenue of $305,722.</li><li>This was 23.57% worse than the analyst estimate for revenue of $400,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/ensc-stock-earnings-ensysce-biosciences-for-q1-of-2024/">ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Ensysce Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ensc-stock-quote/">ENSC</a>) just reported results for the second quarter of 2024.<ul><li>Ensysce Biosciences reported earnings per share of -22 cents. This was above the analyst estimate for EPS of -39 cents.</li><li>The company reported revenue of $181,797.</li><li>This was 39.40% worse than the analyst estimate for revenue of $300,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ensc-stock-earnings-ensysce-biosciences-for-q2-of-2024/">ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q2 2024

Ensysce Biosciences GAAP EPS of -$0.22 beats by $0.11

Ensysce wins $14M federal grant for lead pain therapy

Voxx International Corp., Trinity Biotech Plc, and Ensysce Biosciences are the 3 Penny Stocks to watch on August 29, based on&nbsp;TipRanks' Penny ...

3 Penny Stocks to Watch Now, 8/29/24

Ensysce Biosciences announces $5M concurrent offering, shares fall

Ensysce Biosciences receives non-compliance notice from Nasdaq

ENSC

TRIB

VOXX

Press Releases

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)

Biotech

Offerings

Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants

Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024

Ensysce Biosciences Submits Phase 3 Protocol to the FDA

Ensysce Biosciences Presenting at Upcoming Meetings

Ensysce Biosciences Receives Notice from Nasdaq

Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries

Ensysce Biosciences Announces Leadership Team's Participation in the Annual Pain Therapeutics Summit

Power Nickel Announces Major Copper Discovery as Gold Hits Historic High more stocks inside….

Ensysce Biosciences Receives Positive Nasdaq Listing Determination

CFTN

DBGI

ENSCW

KAVL

PNPNF

STBX

ABVC BioPharma

Alzamend Neuro

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

BioCardia

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Carmell

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Eterna Therapeutics

Forte Biosciences

Galecto

GT Biopharma

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Mustang Bio

Moleculin Biotech

NKGen Biotech

Organovo Holdings

Plus Therapeutics

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Soligenix

Senti Biosciences

Vaccinex

Vincerx Pharma

Viracta Therapeutics, Inc. - Common Stock

Viracta Therapeutics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

HC Wainwright & Co.

Lake Street

WIIM

Ensysce Biosciences shares are trading higher after the company announced it received notice that it may continue its listing on the Nasdaq capital market.

Comments

Ensysce Biosciences

ニュース

最新ニュース Ensysce Biosciences (NASDAQ:ENSC) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル